Adenocarcinoma-reactive human monoclonal antibody MS2B6 defines an antigen in simple glandular epithelium

M. S. Glasky, A. Yin, Lloyd H Smith, M. Bieber, N. N H Teng

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

A human monoclonal antibody (MAb), MS2B6, produced from splenocytes isolated from a patient with advanced papillary serous cystadenocarcinoma of the ovary, defines a unique human tumor-associated antigen. This antigen, EA2B6 (epithelial antigen 2B6), is expressed in a tissue-restricted manner on cultured and fresh human adenocarcinomas and some normal glandular epithelial tissues. EA2B6 is a 38-48 kD protein antigen that co-fractionates with the nuclear matrix-intermediate filament scaffold of simple glandular epithelial tissues. EA2B6 is a molecule with restricted solubility, and in vitro antigen-antibody binding is dependent on the antigen being presented on a solid support. To determine if EA2B6 is a cytokeratin, competition studies were undertaken with several cytokeratin-specific murine monoclonal antibodies. None of these antibodies inhibited the binding of human MAb MS2B6 to partially purified EA2B6. Less than 1% of HT29 colon adenocarcinoma cells and fresh ovarian adenocarcinoma ascites cells express EA2B6 on their surface. The majority of EA2B6 is intracellular. Because of the restricted tissue distribution of this antigen and stability of the antibody, we believe MS2B6 is a good candidate for MAb-mediated diagnosis and therapy of human adenocarcinomas.

Original languageEnglish (US)
Pages (from-to)114-122
Number of pages9
JournalHuman Antibodies and Hybridomas
Volume3
Issue number3
StatePublished - 1992

Fingerprint

Adenocarcinoma
Epithelium
Monoclonal Antibodies
Antigens
Keratins
Antibodies
Papillary Cystadenocarcinoma
Serous Cystadenocarcinoma
Nuclear Matrix
Intermediate Filaments
Neoplasm Antigens
Tissue Distribution
Ascites
Solubility
Ovary
Colon
Epithelial Cells

ASJC Scopus subject areas

  • Immunology

Cite this

Adenocarcinoma-reactive human monoclonal antibody MS2B6 defines an antigen in simple glandular epithelium. / Glasky, M. S.; Yin, A.; Smith, Lloyd H; Bieber, M.; Teng, N. N H.

In: Human Antibodies and Hybridomas, Vol. 3, No. 3, 1992, p. 114-122.

Research output: Contribution to journalArticle

@article{84c5099f7ca341ca855484f3ec6992d4,
title = "Adenocarcinoma-reactive human monoclonal antibody MS2B6 defines an antigen in simple glandular epithelium",
abstract = "A human monoclonal antibody (MAb), MS2B6, produced from splenocytes isolated from a patient with advanced papillary serous cystadenocarcinoma of the ovary, defines a unique human tumor-associated antigen. This antigen, EA2B6 (epithelial antigen 2B6), is expressed in a tissue-restricted manner on cultured and fresh human adenocarcinomas and some normal glandular epithelial tissues. EA2B6 is a 38-48 kD protein antigen that co-fractionates with the nuclear matrix-intermediate filament scaffold of simple glandular epithelial tissues. EA2B6 is a molecule with restricted solubility, and in vitro antigen-antibody binding is dependent on the antigen being presented on a solid support. To determine if EA2B6 is a cytokeratin, competition studies were undertaken with several cytokeratin-specific murine monoclonal antibodies. None of these antibodies inhibited the binding of human MAb MS2B6 to partially purified EA2B6. Less than 1{\%} of HT29 colon adenocarcinoma cells and fresh ovarian adenocarcinoma ascites cells express EA2B6 on their surface. The majority of EA2B6 is intracellular. Because of the restricted tissue distribution of this antigen and stability of the antibody, we believe MS2B6 is a good candidate for MAb-mediated diagnosis and therapy of human adenocarcinomas.",
author = "Glasky, {M. S.} and A. Yin and Smith, {Lloyd H} and M. Bieber and Teng, {N. N H}",
year = "1992",
language = "English (US)",
volume = "3",
pages = "114--122",
journal = "Human Antibodies",
issn = "1093-2607",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Adenocarcinoma-reactive human monoclonal antibody MS2B6 defines an antigen in simple glandular epithelium

AU - Glasky, M. S.

AU - Yin, A.

AU - Smith, Lloyd H

AU - Bieber, M.

AU - Teng, N. N H

PY - 1992

Y1 - 1992

N2 - A human monoclonal antibody (MAb), MS2B6, produced from splenocytes isolated from a patient with advanced papillary serous cystadenocarcinoma of the ovary, defines a unique human tumor-associated antigen. This antigen, EA2B6 (epithelial antigen 2B6), is expressed in a tissue-restricted manner on cultured and fresh human adenocarcinomas and some normal glandular epithelial tissues. EA2B6 is a 38-48 kD protein antigen that co-fractionates with the nuclear matrix-intermediate filament scaffold of simple glandular epithelial tissues. EA2B6 is a molecule with restricted solubility, and in vitro antigen-antibody binding is dependent on the antigen being presented on a solid support. To determine if EA2B6 is a cytokeratin, competition studies were undertaken with several cytokeratin-specific murine monoclonal antibodies. None of these antibodies inhibited the binding of human MAb MS2B6 to partially purified EA2B6. Less than 1% of HT29 colon adenocarcinoma cells and fresh ovarian adenocarcinoma ascites cells express EA2B6 on their surface. The majority of EA2B6 is intracellular. Because of the restricted tissue distribution of this antigen and stability of the antibody, we believe MS2B6 is a good candidate for MAb-mediated diagnosis and therapy of human adenocarcinomas.

AB - A human monoclonal antibody (MAb), MS2B6, produced from splenocytes isolated from a patient with advanced papillary serous cystadenocarcinoma of the ovary, defines a unique human tumor-associated antigen. This antigen, EA2B6 (epithelial antigen 2B6), is expressed in a tissue-restricted manner on cultured and fresh human adenocarcinomas and some normal glandular epithelial tissues. EA2B6 is a 38-48 kD protein antigen that co-fractionates with the nuclear matrix-intermediate filament scaffold of simple glandular epithelial tissues. EA2B6 is a molecule with restricted solubility, and in vitro antigen-antibody binding is dependent on the antigen being presented on a solid support. To determine if EA2B6 is a cytokeratin, competition studies were undertaken with several cytokeratin-specific murine monoclonal antibodies. None of these antibodies inhibited the binding of human MAb MS2B6 to partially purified EA2B6. Less than 1% of HT29 colon adenocarcinoma cells and fresh ovarian adenocarcinoma ascites cells express EA2B6 on their surface. The majority of EA2B6 is intracellular. Because of the restricted tissue distribution of this antigen and stability of the antibody, we believe MS2B6 is a good candidate for MAb-mediated diagnosis and therapy of human adenocarcinomas.

UR - http://www.scopus.com/inward/record.url?scp=0026646971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026646971&partnerID=8YFLogxK

M3 - Article

C2 - 1382650

AN - SCOPUS:0026646971

VL - 3

SP - 114

EP - 122

JO - Human Antibodies

JF - Human Antibodies

SN - 1093-2607

IS - 3

ER -